Clinical Trials Browser

Phase 1/2 × Bevacizumab × Other hematologic neoplasm × Clear all

Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Leukemia, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myelomonocytic, Chronic, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative

Clinical Trials

Bevacizumab in Treating Patients With Myelodysplastic Syndrome